← All Sponsors
SPONSOR

Adcendo ApS

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 1
Conditions studied: Metastatic Soft Tissue SarcomaUnresectable Soft Tissue SarcomaAdvanced Solid Tumor

Clinical Trials by Adcendo ApS

NCT06797999 Phase 1, Phase 2
Recruiting

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

Metastatic Soft Tissue Sarcoma
United States, Belgium, France View Trial →
NCT06597721 Phase 1
Recruiting

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

Advanced Solid Tumor
United States, Australia View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology